The Mitochondrial Research Archive

A curated library of peer-reviewed literature exploring the frontiers of cellular energy,
metabolic resilience, and the science of human vitality.

Epicatechin and PXR Signaling in Skeletal Muscle

Study Title: PXR is a target of (-)-epicatechin in skeletal muscle

Citation: Ortiz-Flores et al., 2020 · Heliyon

What the Study Found: This study examined whether pregnane X receptor, or PXR, may be one of the molecular targets involved in (-)-epicatechin’s effects on skeletal muscle. The researchers used computational docking, C2C12 muscle cells, and mouse skeletal muscle tissue. Their results showed that (-)-epicatechin interacted with the ligand-binding domain of PXR and influenced PXR-related signaling. In muscle cells and mouse muscle, (-)-epicatechin increased PXR expression and was associated with changes in markers linked to muscle growth, differentiation, and metabolism.

What this means in real life: This study helps explain a possible pathway through which (-)-epicatechin may influence skeletal muscle biology. Instead of acting only as a general antioxidant, (-)-epicatechin may interact with specific cellular signaling systems, including PXR. This does not mean it treats muscle disease or guarantees muscle growth in humans. It does support the idea that (-)-epicatechin’s effects may involve receptor-linked signaling pathways that help regulate muscle cell activity and metabolic function.

Clinical Relevance: Cell, computational, and mouse skeletal muscle study, (-)-epicatechin, PXR signaling, muscle growth markers, differentiation, and metabolism model.

Related Content: